Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Idebenone plus escitalopram for post-stroke depression
ChiCTR2500111442Phase 4Not yet recruiting
- Sponsor
- Xuanwu Hospital
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in major depressive disorder (MDD) comparing Idebenone + escitalopram with Placebo idebenone + escitalopram (2 arms). Primary endpoint: HAMD-24 change from baseline to Week 12. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
idebenone
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on ChiCTR2500111442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500111442.